On the public citation graph
Global burden of NAFLD and chronic liver disease among adolescents and young adults
0 signed · 262 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2018.3060openalex-snapshot
Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016
inferredcites →https://doi.org/10.1002/hep.30251openalex-snapshot
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1002/hep.31173openalex-snapshot
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD
inferredcites →https://doi.org/10.1002/hep4.1599openalex-snapshot
The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007‐2017
inferredcites →https://doi.org/10.1016/j.cld.2015.10.001openalex-snapshot
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World
inferredcites →https://doi.org/10.1016/j.jhep.2019.06.021openalex-snapshot
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/s0140-6736(17)32129-3openalex-snapshot
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
inferredcites →https://doi.org/10.1016/s0140-6736(20)30925-9openalex-snapshot
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
inferredcites →https://doi.org/10.1016/s2213-8587(17)30186-9openalex-snapshot
Type 2 diabetes in adolescents and young adults
inferredcites →https://doi.org/10.1016/s2468-1253(19)30349-8openalex-snapshot
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
inferredcites →https://doi.org/10.1056/nejmoa1713231openalex-snapshot
Change in Overweight from Childhood to Early Adulthood and Risk of Type 2 Diabetes
inferredcites →https://doi.org/10.1111/j.1365-2036.2010.04266.xopenalex-snapshot
Clinical predictors of fibrosis in patients with chronic liver disease
inferredcites →https://doi.org/10.1136/gutjnl-2019-318813openalex-snapshot
Epidemiology of chronic liver diseases in the USA in the past three decades
inferredcites →https://doi.org/10.1186/s12916-019-1449-8openalex-snapshot
The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action
inferredcites →https://doi.org/10.2337/dc19-1988openalex-snapshot
Adolescent Obesity and Early-Onset Type 2 Diabetes
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4771342openalex-extracted
Evaluating the Effect of Dual GIPR/GLP-1R Agonists on Non-Alcoholic Fatty Liver Disease and Metabolic Risk Abnormalities: A Drug-Target Mendelian Randomization Study
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2023.35511openalex-snapshot
New-Onset Age of Nonalcoholic Fatty Liver Disease and Cancer Risk
inferred← citeshttps://doi.org/10.1002/adbi.202500232openalex-snapshot
Burden, Trends and Prediction of NAFLD/MAFLD Attributable to Smoking From 1990 to 2021: GBD 2021 Analysis
inferred← citeshttps://doi.org/10.1002/advs.76420openalex-snapshot
Bioengineered Exosome‐Loaded Immunomodulatory Bioadhesive Spray Reverses Liver Fibrosis and Metabolic Dysfunction That Triggers Beneficial Gut‐Liver Crosstalk in Chronic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/fft2.70322openalex-snapshot
Phellinus igniarius Polysaccharides Ameliorate Nonalcoholic Fatty Liver Disease Through Suppressing SREBP1
inferred← citeshttps://doi.org/10.1002/fsn3.3468openalex-snapshot
Curcumin protects against bisphenol A‐induced hepatic steatosis by inhibiting cholesterol absorption and synthesis in CD ‐1 mice
inferred← citeshttps://doi.org/10.1002/fsn3.70627openalex-snapshot
The Burden of Nonmalignant Metabolic Dysfunction‐Associated Steatotic Liver Disease in the Western Pacific Region: A Systematic Analysis From 1990 to 2021
inferred← citeshttps://doi.org/10.1002/hep.32360openalex-snapshot
Letter to the editor: Chronic liver disease among adolescents and young adults: Alcohol use disorder identification
inferred← citeshttps://doi.org/10.1002/jpn3.12272openalex-snapshot
Renal impairment is prevalent in pediatric NAFLD/MASLD and associated with disease severity
inferred← citeshttps://doi.org/10.1002/jpn3.70315openalex-snapshot
Paediatric hepatologists: Frame shift from rare diseases to population health policy
inferred← citeshttps://doi.org/10.1002/oby.24130openalex-snapshot
Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen
inferred← citeshttps://doi.org/10.1002/poh2.70036openalex-snapshot
From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic Strategies
inferred← citeshttps://doi.org/10.1007/978-981-97-9519-2_12openalex-snapshot
MASLD in Special Populations
inferred← citeshttps://doi.org/10.1007/s00125-026-06811-5openalex-snapshot
Non-pharmacological treatment of MASLD
inferred← citeshttps://doi.org/10.1007/s00384-023-04522-6openalex-snapshot
Global, regional, and national burden of intestinal obstruction from 1990 to 2019: an analysis from the Global Burden of Disease Study 2019
inferred← citeshttps://doi.org/10.1007/s10029-025-03282-2openalex-snapshot
Trends and cross-country inequalities in the global burden of inguinal, femoral, and abdominal hernia from 1990 to 2021, with projections from 2022 to 2035: a cross-sectional study
inferred← citeshttps://doi.org/10.1007/s10620-024-08437-2openalex-snapshot
An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients
inferred← citeshttps://doi.org/10.1007/s10735-025-10507-2openalex-snapshot
Exploring the role of xanthine oxidase and aldehyde oxidase in metabolic dysfunction-associated steatotic liver disease (MASLD)
inferred← citeshttps://doi.org/10.1007/s11427-024-2722-2openalex-snapshot
Epidemiology of liver diseases: global disease burden and forecasted research trends
inferred← citeshttps://doi.org/10.1007/s12072-023-10531-yopenalex-snapshot
Global, regional, and national burdens of cirrhosis in children and adolescents aged under 19 years from 1990 to 2019
inferred← citeshttps://doi.org/10.1007/s12072-023-10630-wopenalex-snapshot
Artificial intelligence in liver imaging: methods and applications
inferred← citeshttps://doi.org/10.1007/s12668-026-02686-3openalex-snapshot
An In-Vivo Evaluation on the Ameliorative Efficacy of Piperine Incorporated Biopolymeric Nanocomposite Against Paracetamol-induced Liver Damage in Mice
inferred← citeshttps://doi.org/10.1007/s40200-025-01751-0openalex-snapshot
The impact of air pollution on non-alcoholic fatty liver disease: A global ecological analysis of incidence and mortality trends by human development index (1990–2019)
inferred← citeshttps://doi.org/10.1016/j.actpsy.2026.107702openalex-snapshot
Adverse childhood experiences and chronic liver diseases: Dose-response, type-specific associations, and mediation analyses
inferred← citeshttps://doi.org/10.1016/j.ajp.2023.103905openalex-snapshot
Global, regional, and national burdens of depressive disorders in adolescents and young adults aged 10–24 years from 1990 to 2019: A trend analysis based on the Global Burden of Disease Study 2019
inferred← citeshttps://doi.org/10.1016/j.amjms.2024.04.009openalex-snapshot
The role of blood testing in prevention, diagnosis, and management of chronic diseases: A review
inferred← citeshttps://doi.org/10.1016/j.aohep.2025.101775openalex-snapshot
Association between red blood cell indices and non-alcoholic fatty liver disease: Prospective study and two-sample Mendelian randomization analysis based on large cohorts
inferred← citeshttps://doi.org/10.1016/j.archger.2024.105477openalex-snapshot
Association between biological aging and the risk of mortality in individuals with non-alcoholic fatty liver disease: A prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.archger.2024.105700openalex-snapshot
Global burden of non-rheumatic valvular heart disease in older adults (60–89 years old), 1990–2019: Systematic analysis of the Global Burden of Disease Study 2019
inferred← citeshttps://doi.org/10.1016/j.autrev.2023.103359openalex-snapshot
Temporal trends in the prevalence of autoimmune diseases from 1990 to 2019
inferred← citeshttps://doi.org/10.1016/j.autrev.2023.103450openalex-snapshot
Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in women of childbearing age from 1990 to 2019
inferred← citeshttps://doi.org/10.1016/j.bcp.2023.115989openalex-snapshot
Direct degradation and stabilization of proteins: New horizons in treatment of nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2025.123140openalex-snapshot
Exosomal miRNA combined with anti-inflammatory hyaluronic acid-based 3D bioprinted hepatic patch promotes metabolic reprogramming in NAFLD-mediated fibrosis
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.116331openalex-snapshot
Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist
inferred← citeshttps://doi.org/10.1016/j.cell.2022.09.031openalex-snapshot
En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH
inferred← citeshttps://doi.org/10.1016/j.cgh.2023.04.015openalex-snapshot
The Global Burden of Liver Disease
inferred← citeshttps://doi.org/10.1016/j.cgh.2023.08.020openalex-snapshot
Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women
inferred← citeshttps://doi.org/10.1016/j.cgh.2024.08.020openalex-snapshot
Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysis
inferred← citeshttps://doi.org/10.1016/j.cld.2023.01.022openalex-snapshot
Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/j.cld.2025.04.003openalex-snapshot
The Liver in Diabetes and Metabolic Syndrome
inferred← citeshttps://doi.org/10.1016/j.cld.2026.01.001openalex-snapshot
Metabolic Dysfunction-Associated Steatotic Liver Disease
inferred← citeshttps://doi.org/10.1016/j.clnesp.2025.04.026openalex-snapshot
The extrahepatic markers in postmenopausal women with metabolic dysfunction-associated steatotic liver disease: A systematic review
inferred← citeshttps://doi.org/10.1016/j.cmet.2023.06.012openalex-snapshot
Nonalcoholic fatty liver disease mortality may not be decreasing: A need for careful interpretation of GBD 2019 estimates of liver deaths
inferred← citeshttps://doi.org/10.1016/j.cppeds.2025.101888openalex-snapshot
The learning curve of a pediatric bariatric surgery program: Lessons learned from the first 100 patients
inferred← citeshttps://doi.org/10.1016/j.eclinm.2024.102840openalex-snapshot
Global, regional, and national burden of preterm birth, 1990–2021: a systematic analysis from the global burden of disease study 2021
inferred← citeshttps://doi.org/10.1016/j.ejca.2026.116228openalex-snapshot
Associations between changes in MASLD status and cancer development in young adults: A nationwide cohort study
inferred← citeshttps://doi.org/10.1016/j.ejim.2024.04.013openalex-snapshot
Metabolic dysfunction-associated steatotic liver disease: Evolution of the final terminology
inferred← citeshttps://doi.org/10.1016/j.ejphar.2025.178088openalex-snapshot
Evaluating causal protective effect of dual GLP-1R/GIPR agonists on MASLD: A Mendelian randomization and colocalization study
inferred← citeshttps://doi.org/10.1016/j.envpol.2024.124724openalex-snapshot
Insufficient FUNDC1-dependent mitophagy due to early environmental cadmium exposure triggers mitochondrial redox imbalance to aggravate diet-induced lipotoxicity
inferred← citeshttps://doi.org/10.1016/j.eprac.2023.06.012openalex-snapshot
Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease in Endocrinology Clinics
inferred← citeshttps://doi.org/10.1016/j.fitote.2023.105704openalex-snapshot
Active ingredients of Erhuang Quzhi Granules for treating non-alcoholic fatty liver disease based on the NF-κB/NLRP3 pathway
inferred← citeshttps://doi.org/10.1016/j.fitote.2024.106184openalex-snapshot
Hepatoprotective dibenzocyclooctadiene lignans from the fruits of Kadsura coccinea
inferred← citeshttps://doi.org/10.1016/j.gande.2025.01.003openalex-snapshot
Alcohol-associated liver disease: A review
inferred← citeshttps://doi.org/10.1016/j.glt.2023.09.002openalex-snapshot
Global health burden of cirrhosis and other chronic liver diseases (CLDs) due to non-alcoholic fatty liver disease (NAFLD): A systematic analysis for the global burden of disease study 2019
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e18758openalex-snapshot
A dynamic machine learning model for prediction of NAFLD in a health checkup population: A longitudinal study
inferred← citeshttps://doi.org/10.1016/j.isci.2026.115296openalex-snapshot
Global burden of epilepsy attributable to neonatal disorders in children from 1990 to 2021
inferred← citeshttps://doi.org/10.1016/j.jadohealth.2024.05.009openalex-snapshot
Liver Transplantation Profile Among Teenagers in the United States
inferred← citeshttps://doi.org/10.1016/j.jceh.2022.12.005openalex-snapshot
The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States
inferred← citeshttps://doi.org/10.1016/j.jep.2025.120963openalex-snapshot
Unraveling the potential mechanisms of Bupleuri Radix-Scutellariae Radix herb pair on non-alcoholic fatty liver disease by integrated transcriptomics, metabolomics and network pharmacology
inferred← citeshttps://doi.org/10.1016/j.jff.2023.105715openalex-snapshot
Polyphenolic compounds from Idesia polycarpa Maxim. fruits ameliorate non-alcoholic fatty liver disease by modulating lipid metabolism in oleic acid-induced HepG2 cells and high-fat diet-induced mice
inferred← citeshttps://doi.org/10.1016/j.jhazmat.2025.137166openalex-snapshot
Bisphenol S accelerates the progression of high fat diet-induced NAFLD by triggering ferroptosis via regulating HMGCS2
inferred← citeshttps://doi.org/10.1016/j.jhep.2022.02.012openalex-snapshot
The negative bidirectional interaction between climate change and the prevalence and care of liver disease: A joint BSG, BASL, EASL, and AASLD commentary
inferred← citeshttps://doi.org/10.1016/j.jhep.2023.04.036openalex-snapshot
Changing epidemiology, global trends and implications for outcomes of NAFLD
inferred← citeshttps://doi.org/10.1016/j.jhep.2023.05.034openalex-snapshot
Natural history of NASH cirrhosis in liver transplant waitlist registrants
inferred← citeshttps://doi.org/10.1016/j.jhep.2024.04.027openalex-snapshot
Individuals with cardiometabolic risk factors are at higher risk for early-onset NAFLD
inferred← citeshttps://doi.org/10.1016/j.jhep.2024.05.024openalex-snapshot
Reply to: Correspondence on “clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease’
inferred← citeshttps://doi.org/10.1016/j.jhep.2026.02.016openalex-snapshot
Update in clinical science: MASLD in children and adolescents
inferred← citeshttps://doi.org/10.1016/j.jhepr.2023.100870openalex-snapshot
Sex differences in chronic liver disease and benign liver lesions
inferred← citeshttps://doi.org/10.1016/j.jhepr.2025.101477openalex-snapshot
All-cause and disease-specific mortality in young adults with MASLD: A nationwide cohort study
inferred← citeshttps://doi.org/10.1016/j.lansea.2026.100814openalex-snapshot
Healthcare utilisation, expenditure, and admission-based mortality associated with paediatric hepatobiliary diseases in Thailand: a national database analysis (2015–2023)
inferred← citeshttps://doi.org/10.1016/j.lfs.2026.124669openalex-snapshot
Cyclo(Val-Pro) and cyclo(Phe-Phe) alleviate MASLD via distinct CCR2- and ADCY7-associated pathways
inferred← citeshttps://doi.org/10.1016/j.lungcan.2025.108685openalex-snapshot
Global, regional, and national economic consequences of tracheal, bronchial, and lung cancer
inferred← citeshttps://doi.org/10.1016/j.mayocp.2024.10.021openalex-snapshot
Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021
inferred← citeshttps://doi.org/10.1016/j.metabol.2023.155402openalex-snapshot
The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000–2019
inferred← citeshttps://doi.org/10.1016/j.metabol.2023.155691openalex-snapshot
The global burden of metabolic disease in children and adolescents: Data from the Global Burden of Disease 2000–2019
inferred← citeshttps://doi.org/10.1016/j.metabol.2024.155958openalex-snapshot
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019
inferred← citeshttps://doi.org/10.1016/j.metabol.2026.156549openalex-snapshot
Rising burden of MASLD and CKM syndrome in Asia: A decade of trends and future projections
inferred← citeshttps://doi.org/10.1016/j.metabol.2026.156757openalex-snapshot
Hepatic MED1 disruption ameliorates obesity-related fatty liver by attenuating SREBP1-driven lipogenesis
inferred← citeshttps://doi.org/10.1016/j.pcd.2024.03.005openalex-snapshot
Effects of GLP-1 receptor agonists on the degree of liver fibrosis and CRP in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.puhe.2025.02.028openalex-snapshot
The trend in incidence of non-alcoholic fatty liver disease and its impact on cirrhosis and liver cancer: An analysis from Global Burden of Disease 2021
inferred← citeshttps://doi.org/10.1016/j.tranon.2026.102717openalex-snapshot
Dissecting incidence and mortality inequalities of six types of liver diseases in 39 alcohol-dominant countries and 93 virus-dominant countries under the aging context: Insights from the Global Burden of Disease Study 2021
inferred← citeshttps://doi.org/10.1016/j.transproceed.2023.03.045openalex-snapshot
Factors Predicting Over-Time Weight Increase After Liver Transplantation: A Retrospective Study
inferred← citeshttps://doi.org/10.1016/j.waojou.2026.101422openalex-snapshot
Burden and risk of elderly atopic dermatitis in Europe: A 2021 global burden of disease analysis
inferred← citeshttps://doi.org/10.1016/s2468-1253(22)00317-xopenalex-snapshot
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/s2468-1253(26)00011-7openalex-snapshot
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
inferred← citeshttps://doi.org/10.1038/s41467-025-57616-wopenalex-snapshot
Targeting senescent hepatocytes for treatment of metabolic dysfunction-associated steatotic liver disease and multi-organ dysfunction
inferred← citeshttps://doi.org/10.1038/s41569-025-01220-4openalex-snapshot
The global cardiovascular–liver–metabolic syndemic: epidemiology, trends and challenges
inferred← citeshttps://doi.org/10.1038/s41575-024-00959-4openalex-snapshot
Food inequity and insecurity and MASLD: burden, challenges, and interventions
inferred← citeshttps://doi.org/10.1038/s41575-026-01198-5openalex-snapshot
Lifespan approaches for the prevention and management of steatotic liver disease
inferred← citeshttps://doi.org/10.1038/s41598-023-34942-xopenalex-snapshot
Usefulness of health checkup for screening metabolic dysfunction-associated fatty liver disease and alcohol-related liver disease in Japanese male young adults
inferred← citeshttps://doi.org/10.1038/s41598-024-56085-3openalex-snapshot
Comparative evaluation of non-invasive tests for risk stratification for cause specific mortality in at-risk population of hepatic fibrosis
inferred← citeshttps://doi.org/10.1038/s41598-024-66574-0openalex-snapshot
Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative colitis
inferred← citeshttps://doi.org/10.1038/s41598-025-02031-wopenalex-snapshot
Epidemiological and demographic analysis of liver cancer attributable to modifiable risk factors from 1990 to 2021
inferred← citeshttps://doi.org/10.1038/s41598-025-08434-zopenalex-snapshot
Cost-effectiveness of advanced hepatic fibrosis screening in individuals with suspected MASLD identified by serologic noninvasive tests
inferred← citeshttps://doi.org/10.1038/s41598-025-11976-xopenalex-snapshot
The impact of parity on the risk of nonalcoholic fatty liver disease defined by hepatic steatosis index: A nationwide cohort study
inferred← citeshttps://doi.org/10.1038/s41598-025-26346-wopenalex-snapshot
Prevalence and health checkup-based detection of metabolic dysfunction-associated steatotic liver disease in Japanese young adults
inferred← citeshttps://doi.org/10.1038/s41598-025-97404-6openalex-snapshot
Global trends in prevalence, disability adjusted life years, and risk factors for early onset dementia from 1990 to 2021
inferred← citeshttps://doi.org/10.1038/s41598-025-98489-9openalex-snapshot
Global burden trends and forecasts for MAFLD in adolescents and young adults from 1990 to 2021
inferred← citeshttps://doi.org/10.1038/s41598-025-99540-5openalex-snapshot
Nonlinear association between body roundness index and metabolic dysfunction associated steatotic liver disease in nondiabetic Japanese adults
inferred← citeshttps://doi.org/10.1038/s43856-024-00465-3openalex-snapshot
Transcriptomics-driven metabolic pathway analysis reveals similar alterations in lipid metabolism in mouse MASH model and human
inferred← citeshttps://doi.org/10.1039/d2lc00940dopenalex-snapshot
Opportunities and considerations for studying liver disease with microphysiological systems on a chip
inferred← citeshttps://doi.org/10.1039/d4fo00292jopenalex-snapshot
Hexane insoluble fraction from purple rice extract improves steatohepatitis and fibrosis via inhibition of NF-κB and JNK signaling
inferred← citeshttps://doi.org/10.1039/d4fo01605jopenalex-snapshot
Glycine attenuates high fructose-induced liver injury in adolescent mice by modulating lipid metabolism and gut microbiota
inferred← citeshttps://doi.org/10.1053/j.gastro.2022.02.020openalex-snapshot
The Negative Bidirectional Interaction Between Climate Change and the Prevalence and Care of Liver Disease: A Joint BSG, BASL, EASL, and AASLD Commentary
inferred← citeshttps://doi.org/10.1080/09540105.2025.2496499openalex-snapshot
Harnessing nutrition to combat MASLD: a comprehensive guide to food-based therapeutic strategies
inferred← citeshttps://doi.org/10.1080/16549716.2025.2560711openalex-snapshot
Global, regional, and national burden of ischemic heart disease and ischemic stroke and their risk factors in youths and young adults aged 15–39 years (1990–2021): a comparative analysis of risk factors from global burden of disease study 2021
inferred← citeshttps://doi.org/10.1080/17474124.2023.2298261openalex-snapshot
Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure
inferred← citeshttps://doi.org/10.1080/17474124.2025.2600386openalex-snapshot
From liver to gut: the hidden gastrointestinal impact of pediatric metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1080/19490976.2024.2351620openalex-snapshot
Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine
inferred← citeshttps://doi.org/10.1080/87559129.2026.2715569openalex-snapshot
Dietary Inulin Alleviates NAFLD Through Regulating the Gut Microbiota and Metabolic Signaling Pathways
inferred← citeshttps://doi.org/10.1093/bjs/znaf102openalex-snapshot
Early-onset gastrointestinal cancers: comprehensive review and future directions
inferred← citeshttps://doi.org/10.1093/gastro/goaf056openalex-snapshot
Metabolic dysfunction-associated steatotic liver disease is associated with the risk of severe liver fibrosis in pediatric population
inferred← citeshttps://doi.org/10.1093/radadv/umaf038openalex-snapshot
Multifrequency MR elastography for grading inflammation in metabolic dysfunction-associated steatotic liver disease: a pilot study
inferred← citeshttps://doi.org/10.1093/toxsci/kfac106openalex-snapshot
The imprinted geneZac1regulates steatosis in developmental cadmium-induced nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1093/toxsci/kfag073openalex-snapshot
Hepatic inflammation after exposure to a mixture of low-dose arsenic and cadmium in a murine model of fatty liver disease
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000251openalex-snapshot
The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000352openalex-snapshot
The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction–associated steatotic liver disease and alcohol-associated liver disease
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000755openalex-snapshot
Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017–March 2020
inferred← citeshttps://doi.org/10.1097/hep.0000000000000043openalex-snapshot
Examining the interim proposal for name change to steatotic liver disease in the US population
inferred← citeshttps://doi.org/10.1097/hep.0000000000000383openalex-snapshot
Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019
inferred← citeshttps://doi.org/10.1097/hep.0000000000000507openalex-snapshot
Rising tide of NAFLD in youth: A warning bell and call to action
inferred← citeshttps://doi.org/10.1097/js9.0000000000002647openalex-snapshot
Global, regional, and national burden of endometriosis among women of childbearing age from 1990 to 2021: a cross-sectional analysis from the 2021 global burden of disease study
inferred← citeshttps://doi.org/10.1097/js9.0000000000003723openalex-snapshot
Global, regional, and national burden of low vision and blindness due to glaucoma, 1990–2021, and projections to 2050: a systematic analysis of glaucoma
inferred← citeshttps://doi.org/10.1097/mcg.0000000000001926openalex-snapshot
Mild Thrombocytopenia, a Predictor of Outcomes After Laparoscopic Cholecystectomy
inferred← citeshttps://doi.org/10.1097/md.0000000000033666openalex-snapshot
Geographical disparities in hepatitis b virus related hepatocellular carcinoma mortality rates worldwide from 1990 to 2019
inferred← citeshttps://doi.org/10.1097/md.0000000000047365openalex-snapshot
Association between blood heavy metal levels and subtypes of steatotic liver disease: A nationally representative cross-sectional analysis in South Korea
inferred← citeshttps://doi.org/10.1101/2023.01.18.523503openalex-snapshot
Hepatocyte-specific miR-33 deletion attenuates NAFLD-NASH-HCC progression
inferred← citeshttps://doi.org/10.1111/apa.70373openalex-snapshot
Alarming Global Rise in Adolescent Metabolic Dysfunction‐Associated Steatotic Liver Disease by 2030
inferred← citeshttps://doi.org/10.1111/apt.17158openalex-snapshot
Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world
inferred← citeshttps://doi.org/10.1111/apt.17714openalex-snapshot
The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis
inferred← citeshttps://doi.org/10.1111/apt.18101openalex-snapshot
Global epidemiology of alcohol‐associated liver disease in adolescents and young adults
inferred← citeshttps://doi.org/10.1111/apt.70020openalex-snapshot
Addressing the High and Rising Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ) and Metabolic Dysfunction‐Associated Steatohepatitis ( MASH ): From the Growing Prevalence to Payors' Perspective
inferred← citeshttps://doi.org/10.1111/hepr.70067openalex-snapshot
Young Adults Are at Highest Risk of Liver Fibrosis and Mortality Associated With Steatotic Liver Disease With Metabolic Dysfunction and Alcohol Consumption
inferred← citeshttps://doi.org/10.1111/jgh.70533openalex-snapshot
Chronic Viral Hepatitis With MASLD: Implications for Clinical and Patient‐Reported Outcomes
inferred← citeshttps://doi.org/10.1111/jvh.13903openalex-snapshot
International disease burden of acute viral hepatitis among adolescents and young adults: An observational study
inferred← citeshttps://doi.org/10.1111/liv.15838openalex-snapshot
Cost‐effectiveness study of FIB ‐4 followed by transient elastography screening strategy for advanced hepatic fibrosis in a NAFLD at‐risk population
inferred← citeshttps://doi.org/10.1111/liv.70155openalex-snapshot
Global Burden of Chronic Liver Disease and Temporal Trends: A Population‐Based Analysis From 1990 to 2021 With Projections to 2050
inferred← citeshttps://doi.org/10.1136/bmjopen-2024-085753openalex-snapshot
Association of occupational noise exposure and shift work with non-alcoholic fatty liver disease: a cross-sectional study of male workers in the Chinese automobile manufacturing industry
inferred← citeshttps://doi.org/10.1136/bmjopen-2025-103432openalex-snapshot
Shifting burden of inflammatory bowel disease in women of childbearing age: from high-income to low-income countries (1990–2021)
inferred← citeshttps://doi.org/10.1136/bmjopen-2026-117491openalex-snapshot
Diagnostic performance of neck circumference for detecting steatotic liver disease in adults: a systematic review and meta-analysis protocol
inferred← citeshttps://doi.org/10.1136/flgastro-2026-103825openalex-snapshot
Clinical spectrum of paediatric MASLD: fibrosis burden, steatosis severity and extrahepatic comorbidities in a UK cohort
inferred← citeshttps://doi.org/10.1155/grp/5540686openalex-snapshot
Lactobacillus rhamnosus Ameliorates Dyslipidemia and Liver Steatosis in a Rat Model Fed High‐Fat Diet
inferred← citeshttps://doi.org/10.1155/ijcp/4045868openalex-snapshot
Association of Inflammatory and Nutritional Indices With MASLD in Adolescents: A Cross‐Sectional Study of U.S. and Chinese Populations
inferred← citeshttps://doi.org/10.1159/000538426openalex-snapshot
Liver Stiffness Determined by Transient Elastography Is a Simple and Highly Accurate Predictor for Presence of Liver Cirrhosis in Clinical Routine
inferred← citeshttps://doi.org/10.1159/000546067openalex-snapshot
Global Burden of Ischemic Stroke in Middle-Aged Workforce Population, 1990–2021: Systematic Analysis of the Global Burden of Disease Study 2021
inferred← citeshttps://doi.org/10.1161/circresaha.123.322055openalex-snapshot
Gut Microbiota and Microbial Metabolism in Early Risk of Cardiometabolic Disease
inferred← citeshttps://doi.org/10.1172/jci.insight.168476openalex-snapshot
miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression
inferred← citeshttps://doi.org/10.1177/15578518251363914openalex-snapshot
Analysis of Health-Related Quality of Life and Its Influencing Factors Among Patients with Non-Alcoholic Fatty Liver Disease in Hangzhou, China: A Cross-Sectional Study
inferred← citeshttps://doi.org/10.1177/15578518251371498openalex-snapshot
Unveiling the Silent Threat: Metabolic Dysfunction-Associated Steatotic Liver Disease Risk in Young Adults Through Noninvasive Assessment
inferred← citeshttps://doi.org/10.1177/17474930241246955openalex-snapshot
Global, regional, and national burden of stroke from 1990 to 2019: A temporal trend analysis based on the Global Burden of Disease Study 2019
inferred← citeshttps://doi.org/10.1177/20406223241264539openalex-snapshot
Lack of awareness and ethnic polarity is a major cause of metabolic associated fatty liver disease in high-risk diabetes population in South London
inferred← citeshttps://doi.org/10.1186/s12883-025-04331-0openalex-snapshot
Global, regional and national burdens of epilepsy in the adolescents and young adults from 1990 to 2021 and its predictions
inferred← citeshttps://doi.org/10.1186/s12889-024-19755-5openalex-snapshot
Trends in transport injuries burden and risk factors among children under 14 years old in China: 1990–2019
inferred← citeshttps://doi.org/10.1186/s12889-025-23997-2openalex-snapshot
Burdens of sense organ diseases across global, regional, and national levels from 1990 to 2021 and projections for 2050
inferred← citeshttps://doi.org/10.1186/s12889-025-25378-1openalex-snapshot
The effect of air pollution on chronic liver disease and the modifying effect of physical activity: a nationwide study from CHARLS
inferred← citeshttps://doi.org/10.1186/s12913-025-12737-2openalex-snapshot
A cluster randomized trial of a Multicomponent Clinical Care Pathway (MCCP) to improve MASLD diagnosis and management in primary care: study protocol
inferred← citeshttps://doi.org/10.1186/s12916-023-02925-4openalex-snapshot
Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15–39 years in 204 countries/territories, 1990–2019: a systematic analysis of Global Burden of Disease Study 2019
inferred← citeshttps://doi.org/10.1186/s12916-024-03802-4openalex-snapshot
The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study
inferred← citeshttps://doi.org/10.1186/s12944-025-02750-zopenalex-snapshot
The burden of NAFLD (now referred to as MASLD)-related chronic liver disease and cirrhosis from 1990 to 2021 with projections to 2036: a comparative study of global China the United States and India
inferred← citeshttps://doi.org/10.1186/s13063-022-06451-1openalex-snapshot
The effect of sesame oil consumption compared to sunflower oil on lipid profile, blood pressure, and anthropometric indices in women with non-alcoholic fatty liver disease: a randomized double-blind controlled trial
inferred← citeshttps://doi.org/10.1186/s13098-022-00885-yopenalex-snapshot
Global burden of nonalcoholic steatohepatitis-related liver cancer, 1990–2019: a systematic analysis for the GBD 2019
inferred← citeshttps://doi.org/10.1186/s13098-025-01870-xopenalex-snapshot
Systemic evaluation of the effects of monomeric GLP-1R-based agonists on MASLD and its complications
inferred← citeshttps://doi.org/10.1186/s13287-023-03605-zopenalex-snapshot
Advancements in the pathogenesis of hepatic osteodystrophy and the potential therapeutic of mesenchymal stromal cells
inferred← citeshttps://doi.org/10.1186/s42506-026-00229-yopenalex-snapshot
Trends in the global burden of appendicitis in children at global, regional, and national levels: An analysis using GBD 2021 data
inferred← citeshttps://doi.org/10.1186/s43066-023-00287-3openalex-snapshot
The novel approach for non-invasive diagnostic biomarkers from an early stage of NAFLD to advanced fibrosis
inferred← citeshttps://doi.org/10.1371/journal.pgph.0005274openalex-snapshot
Global and regional burden and inequalities of oral conditions in children, adolescents, and young adults (0–39 years), 1990 to 2021
inferred← citeshttps://doi.org/10.14218/jcth.2022.00052openalex-snapshot
Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update
inferred← citeshttps://doi.org/10.14302/issn.2578-2371.jslr-23-4446openalex-snapshot
Magnitude and Trends of Chronic Liver Disease: A Retrospective Hospital Based Study in Eastern Amhara Region, Northeast Ethiopia
inferred← citeshttps://doi.org/10.14309/ajg.0000000000002642openalex-snapshot
From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women
inferred← citeshttps://doi.org/10.14309/ajg.0000000000002749openalex-snapshot
Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction–Associated Fatty Liver Disease Among Adolescents in the United States
inferred← citeshttps://doi.org/10.14744/hf.2022.2022.0002openalex-snapshot
The Insidious Danger for Young Adults: Metabolic (Dysfunction) Associated Fatty Liver Disease
inferred← citeshttps://doi.org/10.15829/1728-8800-2025-4094openalex-snapshot
Cardiometabolic risk factors, metabolic profile and body composition in young adults with non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.18332/tid/185566openalex-snapshot
Assessing tobacco-related ischemic stroke in Pakistan (1990–2019): Insights from the Global Burden of Disease Study
inferred← citeshttps://doi.org/10.18332/tid/200196openalex-snapshot
Chronic obstructive pulmonary disease burden attributable to tobacco and the trend change from 1990 to 2021 in China
inferred← citeshttps://doi.org/10.18332/tid/204299openalex-snapshot
The global burden of bladder, kidney, and prostate cancers attributable to smoking from 1990 to 2021 and projections for the next two decades: A cross-sectional study
inferred← citeshttps://doi.org/10.20517/mtod.2022.24openalex-snapshot
The growing prevalence of nonalcoholic fatty liver disease (NAFLD), determined by fatty liver index, amongst young adults in the United States. A 20-year experience
inferred← citeshttps://doi.org/10.20517/mtod.2022.38openalex-snapshot
Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms
inferred← citeshttps://doi.org/10.20524/aog.2024.0891openalex-snapshot
The growing trend of vascular intestinal disorder in young individuals: a 20-year analysis
inferred← citeshttps://doi.org/10.21037/hbsn-21-571openalex-snapshot
Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality
inferred← citeshttps://doi.org/10.21037/hbsn-24-445openalex-snapshot
Getting persuasive about the non-invasive: assessing liver fibrosis in practice—without a biopsy
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1511675/v1openalex-snapshot
Curcumin protects against bisphenol A -induced hepatic steatosis by modulating gut microbiota and liver fat synthesis in CD-1 mice
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1968295/v1openalex-snapshot
Factors Associated with Risk of NAFLD and Progression in Multiethnic Asians. A Latent Class and Machine Learning Analysis
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3277463/v1openalex-snapshot
Global, Regional, and National Burdens of Hepatitis B-Associated Cirrhosis in Children and Adolescents from 1990 to 2019 and Joinpoint Regression
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3866756/v1openalex-snapshot
Cytomorphological changes in urine of Sudanese patients diagnosed with hepatitis B virus
inferred← citeshttps://doi.org/10.21203/rs.3.rs-6881341/v1openalex-snapshot
Global Trends and Burden of Infertility Attributable to Polycystic Ovary Syndrome, 1990–2021: A Comprehensive Analysis from the Global Burden of Disease Study
inferred← citeshttps://doi.org/10.21203/rs.3.rs-7647383/v1openalex-snapshot
Shifting Trends and Persistent Disparities in Mortality Related to Liver Cirrhosis and Respiratory Disease: A Population-Based Study in the United States, 1999-2023
inferred← citeshttps://doi.org/10.2139/ssrn.4883930openalex-snapshot
Hepatoprotective Dibenzocyclooctadiene Lignans from the Fruits of Kadsura Coccinea
inferred← citeshttps://doi.org/10.2139/ssrn.5024400openalex-snapshot
All-Cause and Disease-Specific Mortality in Young Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Cohort Study
inferred← citeshttps://doi.org/10.2139/ssrn.5166279openalex-snapshot
Urbanization as a Driving Factor of Global Burden of Non-Alcoholic Fatty Liver Disease: Based on the Global Burden of Disease Study 2021
inferred← citeshttps://doi.org/10.2139/ssrn.5378837openalex-snapshot
Unraveling the Potential Mechanisms of Bupleuri Radix-Scutellariae Radix Herb Pair on Non-Alcoholic Fatty Liver Disease by Integrated Transcriptomics, Metabolomics, and Network Pharmacology
inferred← citeshttps://doi.org/10.2147/dmso.s528506openalex-snapshot
Association of Neutrophil/High-Density Lipoprotein Cholesterol Ratio with Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study and Predictive Model Construction
inferred← citeshttps://doi.org/10.2147/jir.s524204openalex-snapshot
Identification and Validation of Lipid Metabolism-Related Biomarkers GPD1 and CEBPD in Metabolic Dysfunction-Associated Steatohepatitis
inferred← citeshttps://doi.org/10.2147/rmhp.s416592openalex-snapshot
Genetic Variations of AKT1 are Associated with Risk Screening for Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.2337/dci24-0094openalex-snapshot
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
inferred← citeshttps://doi.org/10.30978/mg-2023-6-59openalex-snapshot
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: diagnostic and therapeutic aspects. Review
inferred← citeshttps://doi.org/10.31146/1682-8658-ecg-211-3-120-127openalex-snapshot
Metabolic-associated fatty liver disease (NAFLD) as a cancer risk factor
inferred← citeshttps://doi.org/10.3138/canlivj-2023-0023openalex-snapshot
Breaking boundaries: Unraveling metabolic dysfunction-associated steatotic liver disease in children of India and Canada
inferred← citeshttps://doi.org/10.3329/bsmmcj.v2i2.69844openalex-snapshot
“NASH-Worldwide the Commonest Aetiology of Liver Cirrhosis”- a Review Article
inferred← citeshttps://doi.org/10.3350/cmh.2022.0205openalex-snapshot
Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease
showing the first 200 of 246 · page through all 246
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.